MAASTRICHT, Netherlands--(BUSINESS WIRE)--At the International Mass Spectrometry Conference (IMSC 2022), Bruker Corporation (Nasdaq: BRKR) today announced the launch of the new nanoElute® 2 nano-LC, ...
MALDI-2 Increases Small Molecule Sensitivity by One or Two Orders of Magnitude New prm-PASEF Workflow for Translational 4D Proteomics Large-Scale, High-Precision Peptide CCS Measurements for Deep ...
At the 64th ASMS Conference, Bruker introduces rapifleX™, the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX ...
ATLANTA, May 31, 2019 /PRNewswire/ -- At the 67 th American Society for Mass Spectrometry Conference (ASMS) being held June 2-6 in Atlanta, Bruker is announcing highly innovative new mass spectrometry ...
Bruker Daltonics now has taken the important step of registering its flex (TM) series MALDI-TOF mass spectrometers as medical devices in the Russian Federation, to facilitate upcoming future ...
SAN FRANCISCO, June 20, 2019 /PRNewswire/ -- At the ASM Microbe Conference 2019 (www.asm.org), Bruker launches the new MALDI Biotyper sirius system for all previously FDA-cleared, and for all research ...
This is a Sources Sought notice and not a request for quotes. This request is solely for the purpose of conducting market research to enhance VHA s understanding of your company s offered services and ...
Bruker CorporationBRKR, a renowned name in the field of proprietary life science and materials research systems, recently announced the buyout of InVivo Biotech Services GmbH. This Hennigsdorf, ...
Mass spectrometry has in recent decades been widely used in drug discovery, and CRO AMRI just tapped Bruker Daltonics and HighRes Biosolutions to develop new applications for such services. The core ...
At the virtual ASMS 2020 Reboot conference, Bruker Corporation today announces a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world’s first commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results